Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Receiver Operating Characteristic Plot01:15

Receiver Operating Characteristic Plot

183
A ROC (Receiver Operating Characteristic) plot is a graphical tool used to assess the performance of a binary classification model by illustrating the trade-off between sensitivity (true positive rate) and specificity (false positive rate). By plotting sensitivity against 1 - specificity across various threshold settings, the ROC curve shows how well the model distinguishes between classes, with a curve closer to the top-left corner indicating a more accurate model. The area under the ROC curve...
183
Sensitivity, Specificity, and Predicted Value01:13

Sensitivity, Specificity, and Predicted Value

358
In healthcare diagnostics, laboratory tests play a crucial role in identifying and diagnosing a wide range of medical conditions. However, interpreting test results is not always straightforward. An abnormal test result does not always confirm the presence of a disease, just as a normal result does not guarantee its absence. To assess the reliability of these diagnostic tools, healthcare practitioners rely on two key statistical indicators: sensitivity and specificity.
Sensitivity is the...
358
Model Approaches for Pharmacokinetic Data: Distributed Parameter Models01:06

Model Approaches for Pharmacokinetic Data: Distributed Parameter Models

69
Pharmacokinetic models are mathematical constructs that represent and predict the time course of drug concentrations in the body, providing meaningful pharmacokinetic parameters. These models are categorized into compartment, physiological, and distributed parameter models.
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
69
Model-Independent Approaches for Pharmacokinetic Data: Noncompartmental Analysis00:59

Model-Independent Approaches for Pharmacokinetic Data: Noncompartmental Analysis

64
Noncompartmental analyses offer an alternative method for describing drug pharmacokinetics without relying on a specific compartmental model. In this approach, the drug's pharmacokinetics are assumed to be linear, with the terminal phase log-linear. This assumption allows for simplified analysis and interpretation of the drug's behavior in the body.
One important characteristic of noncompartmental analyses is that drug exposure increases proportionally with increasing doses. This...
64
Steps in Outbreak Investigation01:18

Steps in Outbreak Investigation

131
In the ever-evolving field of public health, statistical analysis serves as a cornerstone for understanding and managing disease outbreaks. By leveraging various statistical tools, health professionals can predict potential outbreaks, analyze ongoing situations, and devise effective responses to mitigate impact. For that to happen, there are a few possible stages of the analysis:
131
Analysis Methods of Pharmacokinetic Data: Model and Model-Independent Approaches01:14

Analysis Methods of Pharmacokinetic Data: Model and Model-Independent Approaches

131
Drug disposition in the body is a complex process and can be studied using two major approaches: the model and the model-independent approaches.
The model approach uses mathematical models to describe changes in drug concentration over time. Pharmacokinetic models help characterize drug behavior in patients, predict drug concentration in the body fluids, calculate optimum dosage regimens, and evaluate the risk of toxicity. However, ensuring that the model fits the experimental data accurately...
131

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Multisite Real-World Validation of an Electronic Health Record-Integrated Generative Artificial Intelligence Tool for Venous Thromboembolism Risk Stratification.

medRxiv : the preprint server for health sciences·2026
Same author

An examination of the availability and characteristics of social needs data in the electronic health records: a path to social data harmonization and standardization at Johns Hopkins medicine.

JAMIA open·2026
Same author

Neuroretinal Layer Thinning on OCT Imaging and Hemoglobin A1c in Youth With Type 1 Diabetes.

JAMA ophthalmology·2026
Same author

Effects of Metabolic Dysregulation on Macrophage Polarization in Rheumatoid Arthritis.

Arthritis & rheumatology (Hoboken, N.J.)·2026
Same author

Beyond Missingness: Systematizing Methods for Comprehensive Data Fitness Assessment in Clinical Research.

Journal of medical Internet research·2026
Same author

The Potential Implications of Informatics for Value-Based Bare.

Journal of the American Medical Informatics Association : JAMIA·2026

Related Experiment Video

Updated: Jul 5, 2025

An R-Based Landscape Validation of a Competing Risk Model
05:37

An R-Based Landscape Validation of a Competing Risk Model

Published on: September 16, 2022

2.1K

Applicability Area: A novel utility-based approach for evaluating predictive models, beyond discrimination.

Star Liu1, Shixiong Wei1, Harold P Lehmann1

  • 1Johns Hopkins University School of Medicine, Baltimore, MD, United States.

AMIA ... Annual Symposium Proceedings. AMIA Symposium
|January 15, 2024
PubMed
Summary
This summary is machine-generated.

We introduce the Applicability Area (ApAr), a new method for evaluating machine learning models in healthcare. ApAr demonstrates a model's clinical utility across various patient populations, offering a more comprehensive assessment than traditional metrics.

More Related Videos

Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances
07:35

Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances

Published on: October 11, 2018

7.5K
Cross-Modal Multivariate Pattern Analysis
13:51

Cross-Modal Multivariate Pattern Analysis

Published on: November 9, 2011

20.0K

Related Experiment Videos

Last Updated: Jul 5, 2025

An R-Based Landscape Validation of a Competing Risk Model
05:37

An R-Based Landscape Validation of a Competing Risk Model

Published on: September 16, 2022

2.1K
Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances
07:35

Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances

Published on: October 11, 2018

7.5K
Cross-Modal Multivariate Pattern Analysis
13:51

Cross-Modal Multivariate Pattern Analysis

Published on: November 9, 2011

20.0K

Area of Science:

  • * Medical Informatics
  • * Machine Learning Evaluation
  • * Clinical Decision Support

Background:

  • * Evaluating machine learning models for clinical practice requires assessing their real-world utility beyond discriminatory power.
  • * Current methods often focus on metrics like Area Under the Receiver Operating Characteristic Curve (AUROC), which do not fully capture clinical decision-making complexities.

Purpose of the Study:

  • * To introduce and evaluate the Applicability Area (ApAr), a novel decision-analytic, utility-based approach for assessing predictive model performance.
  • * To demonstrate how ApAr can provide a more comprehensive evaluation of a model's clinical value compared to existing metrics.

Main Methods:

  • * Development of the Applicability Area (ApAr) metric, which quantifies the range of prior probabilities and test cutoffs where a predictive model offers positive utility.
  • * Validation of ApAr using simulated datasets and three published medical datasets.
  • * Comparison of ApAr rankings with traditional AUROC metric analysis.

Main Results:

  • * The ApAr metric provides additional value in evaluating predictive models, complementing traditional AUROC analysis.
  • * In a diabetes dataset example, the top-ranked model by ApAr was significantly lower ranked by AUROC (23rd), highlighting differing model assessments.
  • * Larger ApAr values indicate a broader range of clinical applicability for the predictive model.

Conclusions:

  • * The Applicability Area (ApAr) offers a superior, utility-based framework for evaluating the clinical value of predictive models.
  • * ApAr assists decision-makers in determining if a model's utility aligns with local clinical contexts and patient populations.
  • * This approach facilitates more informed adoption and implementation of machine learning models in healthcare settings.